Colorado-based next-generation psychedelics biotech Mydecine Innovations Group Inc. (OTC: MYCOF) announced that, in connection with its common share subscription agreement with a third-party investor dated this past March 10, it has filed a shelf prospectus supplement to its final base shelf prospectus for th
FCM Director Candidates, including Dr. Freeman, and Mr. Jake Freeman, Commit to Not Selling Any of Their MindMed Shares Until June 15, 2025
FCM and its Nominees Stand Behind Their Plan to Drive Value for
Details the Ways in Which Dr. Alan Muney, Chair of the Compensation Committee, and Kim Rivera, Chair of the Nominating and Corporate Governance Committee, Have Failed Stockholders
Urges Stockholders to Help Initiate a
Reiterates Commitment to Delivering Shareholder Value
Provides Important Context Regarding Engagement with Seatankers
Recommends Shareholders Vote "FOR" All International Seaways Directors and All Other
https://www.semafor.com/article/05/30/2023/carl-icahns-end-game
Carl Icahn looked to reorganize Icahn Enterprises before a short-seller published a report critical of the company earlier this month, people familiar with
John J. Gebbia Appointed as Chairman of the Board and Chief Executive Officer of Siebert
Kakao Pay's Simon Shin Appointed to Siebert's Board of Directors
Close of Kakao Pay's Investment of $17.4
9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today announced that the Board of Directors has accepted the
Biofrontera Inc. (NASDAQ:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, announces that its Board of